CoMeCT project

This project is funded by the European Union under the Horizon Europe research and innovation programme (GA-101136531). Any related posts reflect only the views of the project. The overall goal of CoMeCT is to coordinate activities across Europe’s strategic adaptive platform trials (APTs) and cohort studies (CS) on infectious diseases (IDs) with epidemic or pandemic potential. It will do so by overseeing and facilitating dialogue, sharing good practices, promoting collaboration and coordination across studies and providing updated information on initiatives and innovation in ID clinical research. CoMeCT will build on and strengthen existing networks and infrastructure. These include EU-funded coordination mechanisms and networks, namely the Trial Coordination Board, Joint Access Advisory Mechanism (JAAM), the Cohort Coordination Board, and the ECRAID Coordinating Committee. CoMeCT will quickly adapt coordination efforts to a changing research landscape and to new ID threats. CoMeCT will operate in close collaboration with other emergency preparedness mechanisms, such as HERA, EMA, GLOPiD-R and the European Pandemic Preparedness Partnership.